PhysiologyNature Cardiovascular ResearchPeer-reviewed
Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy
Laura Sen-Martín, Ángel Fernández‐Trasancos, Miguel Ángel López-Unzu…·Jorge Alegre‐Cebollada
This study shows that myosin inhibition with mavacamten is effective in treating HCM caused by both truncating and missense variants in MYBPC3, despite different pathomechanisms.
1 citation